Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

US Patent 9238692 · Granted Jan 19, 2016

Estimated economic value: $312,973,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices and methods for overfilling drug containers2025
VEGF antagonist formulations suitable for intravitreal administration2025
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2024
Process for reducing subvisible particles in a pharmaceutical formulation2024
Process for reducing subvisible particles in a pharmaceutical formulation2024
Target residual moisture content for lyophilized drug product2024
Methods of reducing particle formation and compositions formed thereby2024
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodie2024
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodie2024
Devices and methods for overfilling drug containers2024
Citrate buffered VEGF antagonist formulations2023
VEGF antagonist formulations suitable for intravitreal administration2023